Activation of RNase L by 2',5'-Oligoadenylates
BIOPHYSICAL CHARACTERIZATION*

(Received for publication, February 26, 1997)

James L. Cole , Steven S. Carroll , Elaine S. Blue , Tracy Viscount and Lawrence C. Kuo

From the Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania 19486

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

Ribonuclease L (RNase L) is an endoribonuclease that is activated upon binding of adenosine oligomers linked 2' to 5' to cleave viral and cellular RNAs. We recently proposed a model for activation in which activator A binds to monomer, E, to form EA, which subsequently dimerizes to the active form, E2A2 (Cole, J. L., Carroll, S. S., and Kuo, L. C. (1996) J. Biol. Chem. 271, 3978-3981). Here, we have employed this model to define the equilibrium constants for activator binding (Ka) and dimerization of EA to E2A2 (Kd) by equilibrium analytical ultracentrifugation and fluorescence measurements. Multi-wavelength sedimentation data were globally fit to the model above, yielding values of Ka = 1.69 µM and Kd = 17.8 nM for 2',5'-linked adenosine trimer. Fluorescent conjugates of 2',5'-linked adenosine trimer with 7-hydroxycoumarin have been prepared. The coumarin emission anisotropy shows a large increases upon binding to RNase L. Analysis of anisotropy titrations yields values of Ka and Kd close to those obtained by sedimentation. The sedimentation parameters for unmodified 2',5'-linked adenosine trimer also agree with those obtained by enzyme kinetic methods (Carroll, S. S., Cole, J. L., Viscount, T., Geib, J., Gehman, J., and Kuo, L. C. (1997) J. Biol. Chem. 272, 19193-19198). Thus, the data presented here clearly define the energetics of RNase L activation and support the minimal activation model.


INTRODUCTION

RNase L is an endoribonuclease involved in the interferon pathway. Upon activation by adenosine oligomers linked 2' to 5', RNase L degrades viral and cellular mRNAs, leading to an inhibition of protein synthesis in virally infected cells (1, 2). It has been demonstrated by gel filtration, chemical cross-linking (3), and analytical ultracentrifugation (4) that RNase L exists as a monomer in solution but is dimerized in the presence of an activator, suggesting that the catalytically active form of RNase L is a homodimer. Under stoichiometric binding conditions, dimerization and activation of RNase L require the binding of one activator molecule per ribonuclease L monomer (4). However, in the absence of an activator, only monomer is observed up to a protein concentration of at least 18 µM, indicating that unliganded enzyme is unable to dimerize, or the association is extremely weak. These observations support a minimal model for RNase L activation depicted in Scheme 1. In the context of this model, the energetics of activation of RNase L are defined by two equilibrium dissociation constants, Ka and Kd. Note that this model is a subset of the full reaction scheme for a coupled ligand binding and enzyme dimerization equilibrium (5, 6). We have also extended this model to include the substrate binding step and employed it to compare the activation of RNase L by analogs of the native activator (7).


[View Larger Version of this Image (14K GIF file)]

Scheme 1.


Under the conditions of our previous sedimentation equilibrium measurements (4 °C), the enzyme concentrations were much higher than either Ka or Kd. Thus, the stoichiometry of the interaction was defined, but the association constants were inaccessible. However, activator binding is highly temperature-dependent, such that at 20 °C association is weaker and directly accessible by biophysical measurements for several activators containing a 5'-OH group. In the present study, we have characterized the binding of several activators with both sedimentation equilibrium and fluorescence anisotropy measurements. The results are compared with those obtained by enzyme kinetic methods in the accompanying paper (7).


MATERIALS AND METHODS

Human RNase L was expressed and purified as described previously (8) and stored in 40% glycerol, 25 mM HEPES, pH 7.5, 100 mM KCl, 5.8 mM MgCl2, and 5 mM DTT.1 To reduce the UV absorbance due to oxidized DTT, the sample buffer (11 mM HEPES, pH 7.5, 104 mM KCl, 5.8 mM MgCl2) was purged of oxygen by bubbling with argon prior to adding 2 mM DTT. The enzyme was equilibrated into the sample buffer using Bio-Rad Biospin 6 spin columns. Protein concentration was measured spectrophotometrically using a molar extinction coefficient at 280 nm of 8.41 ± 0.87 × 104 M-1 cm-1 (4).

The 2',5'-linked adenosine trimer (HO-2',5'-A3) was obtained from the Midland Certified Reagent Company or from Sigma. The activators containing a free 2'-amino group, HO-2',5'-A3-2'-NH2 and p-2',5'-A3-2'-NH2, were obtained from NAPS GmbH, Goettingen, Germany. The oligoribonucleotide concentrations were determined spectrophotometrically using epsilon 260 nm = 1.53 × 104 M-1 cm-1/adenosine. The succinimidyl ester of 7-hydroxycoumarin-3-carboxylic acid (NHS-7HC) was obtained from Molecular Probes.

Fluorescence activators were prepared by reacting NHS-7HC with HO-2',5'-A3-2'-NH2 or p-2',5'-A3-2'-NH2. NHS-7HC was dissolved in N,N-dimethylformamide at a concentration of 5 mM. The conjugation reactions were performed in 50 mM sodium phosphate, pH 7.65, at a concentration of 20 µM oligoribonucleotide, 200 µM NHS-7HC at room temperature for 2 h. The conjugate was purified on reverse phase HPLC using a Vydac C18 column with a linear gradient of acetonitrile (0.5-30% in 30 min, flow rate = 1 ml/min) in 50 mM aqueous triethylammonium acetate, pH 6.8. Representative elution times are: NHS-7HC, 12.95 min; HO-2',5'-A3-2'-NH2, 10.13 min; HO-2',5'-A3-7HC, 15.92 min.

Equilibrium analytical ultracentrifugation were performed using six-channel (1.2-cm path) charcoal-Epon cells with a Beckman XL-A centrifuge and an An-60 Ti rotor at a speed of 14,000 rpm and a temperature of 20 °C unless otherwise indicated. Samples of 110-µl volume were loaded under argon. Scans were recorded at 230 and 260 nm using 0.001-cm point spacing and averaging 10 readings at each point. Equilibrium was judged to be achieved by the absence of systematic deviations in a plot of the difference between successive scans taken 4 h apart.

For fluorescence experiments, 120-µl samples containing fluorescent activator and RNase L were prepared in sample buffer and allowed to equilibrate at least 2 h prior to measurement. Data were collected at 20 °C in 10 × 2-mm Hellma microcuvettes using an ISS K2 fluorometer at an excitation wavelength of 404 (16 nm bandpass), and emission was collected using a Schott KV-470 long pass glass filter. Steady-state anisotropy was measured in the L-format, and instrument G-factors were measured with the excitation polarizer in the horizontal position. Data for both the sample and buffer blank were collected for 2 s in each orientation, and at least three measurements were averaged. Fluorescence lifetime measurements were performed using the phase modulation method over a frequency range of 5-190 MHz. The lifetime reference was Me2POPOP in ethanol, (tau  = 1.45 ns) (9).

Sedimentation equilibrium data were globally fit using the Marquardt-Levenberg least squares algorithm with the SAS software package (SAS Institute, Cary, NC). Within the context of Scheme 1, the concentrations of EA and E2A2 can be expressed in terms of the dissociation constants Ka and Kd and the concentrations of E and A. 
[E<UP>A</UP>]=<FR><NU>[E]<UP> </UP>[<UP>A</UP>]</NU><DE>K<SUB>a</SUB></DE></FR> (Eq. 1)
[E<SUB>2</SUB><UP>A</UP><SUB>2</SUB>]=<FR><NU>[E<UP>A</UP>]<SUP>2</SUP></NU><DE>K<SUB>d</SUB></DE></FR>=<FR><NU>1</NU><DE>K<SUB>d</SUB></DE></FR><FENCE><FR><NU>[E][<UP>A</UP>]</NU><DE>K<SUB>a</SUB></DE></FR></FENCE><SUP>2</SUP> (Eq. 2)

Our method to determine the dissociation constants relies on the differences in the absorption spectra of E and A and is similar to the approach described by Lewis and co-workers (10) to characterize protein-DNA interactions. We can express the absorbance at any wavelength as the sum of the contributions from each of the species participating in the equilibrium
A(&lgr;)=&egr;<SUB>&lgr;,E</SUB>[E]+&egr;<SUB>&lgr;,<UP>A</UP></SUB>[<UP>A</UP>]+(&egr;<SUB>&lgr;,E</SUB>+&egr;<SUB>&lgr;,<UP>A</UP></SUB>)[E<UP>A</UP>]+2(&egr;<SUB>&lgr;,E</SUB>+&egr;<SUB>&lgr;,<UP>A</UP></SUB>)[E<SUB>2</SUB><UP>A</UP><SUB>2</SUB>] (Eq. 3)
where epsilon lambda ,E is the molar extinction coefficient of E at wavelength lambda ; and epsilon lambda ,A is the molar extinction coefficient of A at wavelength lambda . Substituting Equations 1 and 2 into Equation 3 gives the following.
A(&lgr;)=&egr;<SUB>&lgr;,E</SUB>[E]+&egr;<SUB>&lgr;,<UP>A</UP></SUB>[<UP>A</UP>]+(&egr;<SUB>&lgr;,E</SUB>+&egr;<SUB>&lgr;,<UP>A</UP></SUB>)<FR><NU>[E]<UP> </UP>[<UP>A</UP>]</NU><DE>K<SUB>a</SUB></DE></FR> (Eq. 4)
+2(&egr;<SUB>&lgr;,E</SUB>+&egr;<SUB>&lgr;,<UP>A</UP></SUB>)<FR><NU>1</NU><DE>K<SUB>d</SUB></DE></FR><FENCE><FR><NU>[E][<UP>A</UP>]</NU><DE>K<SUB>a</SUB></DE></FR></FENCE><SUP>2</SUP>
Finally, in the presence of a centrifugal field we can express the absorbance at wavelength lambda  and radius r, A(lambda ,r), as
A(&lgr;,r)=&dgr;<SUB>&lgr;</SUB>+&egr;<SUB>&lgr;,E</SUB>C<SUB>0E</SUB>e<SUP>&sfgr;<SUB>E</SUB>&xgr;</SUP>+&egr;<SUB>&lgr;,<UP>A</UP></SUB>C<SUB>0<UP>A</UP></SUB>e<SUP>&sfgr;<SUB><UP>A</UP></SUB>&xgr;</SUP>+(&egr;<SUB>&lgr;,E</SUB>+&egr;<SUB>&lgr;,<UP>A</UP></SUB>)C<SUB>0E</SUB>C<SUB>0<UP>A</UP></SUB>e<SUP><UP>−ln</UP>K<SUB>a</SUB><UP>+</UP>(&sfgr;<SUB>E</SUB>+&sfgr;<SUB><UP>A</UP></SUB>)&xgr;</SUP>+2(&egr;<SUB>&lgr;,E</SUB>+&egr;<SUB>&lgr;,<UP>A</UP></SUB>)(C<SUB>0E</SUB>C<SUB>0<UP>A</UP></SUB>)<SUP>2</SUP>e<SUP><UP>−ln</UP>K<SUB>d</SUB><UP>−</UP>2<UP>ln</UP>K<SUB>a</SUB>+2(&sfgr;<SUB>E</SUB><UP>+</UP>&sfgr;<SUB><UP>A</UP></SUB>)&xgr;</SUP> (Eq. 5)
where delta lambda is the baseline offset at wavelength lambda , C0E is the molar concentration of E at the reference distance r0, sigma E is the reduced molecular weight of E, and xi  = (r2 - r02)/2, C0A and sigma A are defined analogously. The natural logarithms of Ka and Kd are the fitted quantities to constrain the dissociation constants to be positive.

The value of sigma E was experimentally measured by sedimentation equilibrium of RNase L alone at 14,000 rpm, and sigma A was obtained for each activator by sedimentation equilibrium at 45,000 rpm. Because of the low molecular weight of the activators, delta 260 could not be obtained by overspeeding following the run. Therefore, we used a mass conservation method in which delta 260 was measured as the difference in the integrated absorption at 260 nm at equilibrium at 14,000 rpm and the absorbance at 260 nm at the beginning of the run. Because the activators do not contribute much absorbance at 230, delta 230 was measured by overspeeding to 45,000 rpm following the centrifugation experiment at 14,000 rpm. For each experiment three channels containing different activator concentrations were analyzed globally at 230 and 260 nm where C0A and C0E were treated as local fitting parameters, and Ka and Kd were global parameters.

The fluorescence anisotropy titration data were fit using the Marquardt-Levenberg algorithm within the IGOR Pro software package (Wavemetrics, Inc.). From Equations 1 and 2 and mass conservation it can be shown that
[<UP>A</UP>]=<FR><NU><UP>−</UP><FENCE><FR><NU>[E]</NU><DE>K<SUB>a</SUB></DE></FR>+1</FENCE>+<RAD><RCD><FENCE><FR><NU>[E]</NU><DE>K<SUB>a</SUB></DE></FR>+1</FENCE><SUP>2</SUP>+<FR><NU>8</NU><DE>K<SUB>d</SUB></DE></FR><FENCE><FR><NU>[E]</NU><DE>K<SUB>a</SUB></DE></FR></FENCE><SUP>2</SUP>[<UP>A</UP>]<SUB><UP>T</UP></SUB></RCD></RAD></NU><DE><FR><NU>4</NU><DE>K<SUB>d</SUB></DE></FR><FENCE><FR><NU>[E]</NU><DE>K<SUB>a</SUB></DE></FR></FENCE><SUP>2</SUP></DE></FR> (Eq. 6)
where [A]T refers to the total activator concentration. Under conditions where [A]T <<  [E]T one can make the approximation that [E] ~ [E]T. The observed anisotropy robs is given as the sum of the anisotropies of the individual species weighted by the molar concentration of A in each species
r<SUB><UP>obs</UP></SUB>=<FR><NU>([<UP>A</UP>]+[E<UP>A</UP>])r<SUB><UP>f</UP></SUB>+2[E<SUB>2</SUB><UP>A</UP><SUB>2</SUB>]r<SUB><UP>b</UP></SUB>R</NU><DE>[<UP>A</UP>]+[E<UP>A</UP>]+2[E<SUB>2</SUB><UP>A</UP><SUB>2</SUB>]R</DE></FR> (Eq. 7)
where rf is the anisotropy of the free activator A, and rb is anisotropy of the bound activator in the species E2A2. We assign the anisotropy of EA to be equal to rf; the justification is presented below. Equation 7 includes a quenching factor R, which is the ratio of the quantum yields of the free and bound forms (9).

The titrations of RNase L were performed at four activator concentrations under conditions where [A]T <=  5[E]T. The value of R was take to be 0.40 based on the limiting intensity decrease at high enzyme concentration. The value of rf was measured experimentally.

For both the sedimentation and fluorescence experiments the joint confidence intervals for the fitted values of Ka and Kd were obtained by a search of the error surface in which one parameter was fixed, and the all the other parameters were allowed to adjust to their best fit values. This method correctly accounts for the cross-correlation (nonorthogonality) of the fitting parameters and the nonlinearity of the fitting equation (11, 12).


RESULTS

Sedimentation Equilibrium

Our previous studies of activator-induced dimerization of RNase L by sedimentation equilibrium were performed at 4 °C, using conditions where [E] >>  Ka and Kd, so that the stoichiometry could be characterized (4). In contrast, for the weaker activators, such as HO-2',5'-A3, activator-induced dimerization is not stoichiometric at the higher temperature of 20 °C.2 Thus, sedimentation equilibrium data obtained under these conditions may be used to extract Ka and Kd. The radial absorbance profiles contain contributions from each of the species participating in the equilibrium: E, A, EA, and E2A2; these data can be fit to Equation 5 to obtain Ka and Kd. To define the contributions of RNase L and activator at each radial position we have taken advantage of differences in their absorption spectra. Fig. 1 shows that at enzyme and activator concentrations typically used in our experiments the 230 nm absorbance is dominated by the contribution from the enzyme, whereas the 260 nm absorbance is dominated by the activator. Thus, we record data for each channel at both of these wavelengths and fit using a single value of C0A and C0E. To further constrain the fits, data can be obtained at several concentrations of enzyme and activator. We have found that three activator concentrations are sufficient to define Ka and Kd for the activators used in this study.


Fig. 1. Absorption spectra of RNase L and HO-2',5'-A3. (------), RNase L; (- - - - -), activator. The scale on the left refers to RNase L, and the scale on the right refers to activator. The vertical gray lines indicate the wavelengths used for sedimentation data acquisition.
[View Larger Version of this Image (17K GIF file)]

Fig. 2 shows the sedimentation equilibrium data obtained at 230 and 260 nm for samples loaded at a concentration of 0.5 µM RNase L and 1, 3, and 10 µM HO-2',5'-A3. The data have been fit to Equation 5; the solid lines are the best fit to the data, the insets are the residuals, and the results are summarized in Table I. There is a weak positive systematic deviation in the residuals at 230 nm for the data obtained at 1 and 10 µM and a negative deviation for the data obtained at 3 µM. These deviations are likely due to errors in the baseline offset term delta 230. However, outside of these deviations the fit is quite good. Although baseline errors result in higher r.m.s. deviations, in the range of 0-0.02 OD they do not affect the fitted values of Ka or Kd significantly as defined by the 1 S.D. confidence intervals.2


Fig. 2. Analysis of sedimentation equilibrium of RNase L + HO-2',5'-A3. The data were obtained at a concentration of 0.5 µM RNase L and 1 (open circle ), 3 (square ), and 10 (diamond ) µM activator. The data were obtained at a rotor speed of 14,000 rpm and a temperature of 20 °C. The solid lines are a global fit of the data to Scheme I, and the insets are the residuals. The scale for the residuals is -0.05 to 0.05 OD. The results of the fit are given in Table I.
[View Larger Version of this Image (31K GIF file)]

Table I. Ka and Kd values determined by sedimentation equilibrium

Samples were prepared at 20 °C in buffer containing 11 mM HEPES, pH 7.5, 104 mM KCl. 58 mM MgCl2, and 2 mM DTT. Data sets were collected 14,000 rpm from three channels at two wavelengths (230 and 260 nm) and were globally analyzed to obtain Ka and Kd. The values in parentheses refer to the 1 S.D. joint confidence intervals.

Activator Modela Ka Kd r.m.s.b

µM nM
HO-2',5'-A3 1 1.69 (1.24, 2.38) 17.8 (11.9, 24.4) 0.00661
HO-2',5'-A3 2 2.09 ± 10-7 138 0.0107
HO-2',5'-A3-7HC 1 2.67 (1.19, 30.1)  1.72 (0.02, 5.43) 0.00681

a The data were fit according to the models depicted in either Scheme 1 or Scheme 2.
b Root mean square deviation of the fit in absorbance units.

Fig. 3 shows a contour plot of the fit error surface for the data in Fig. 1 as a function of lnKa and lnKd. The values of lnKa and lnKd were fixed, and the other parameters were allowed to adjust to the best fit values. The inner contour is drawn at 1 S.D., and the outer contour is at 2 S.D. joint confidence intervals. The shape of the contours is typical for a system exhibiting parameter cross-correlation (12). In our case, there is negative correlation between lnKa and lnKd. Despite this correlation, the system exhibits a single, well defined fit minimum. As shown in Table I, the 1 S.D. joint confidence intervals correspond to about a 2-fold change in either Ka or Kd.


Fig. 3. Contour plot of the HO-2',5'-A3 fit error surface as a function of lnKa and lnKd. The values of lnKa and lnKd were fixed, and all of the other parameters were allowed to adjust to the best fit values. The inner contour is drawn at 1 S.D., and the outer contour is at 2 S.D. joint confidence intervals.
[View Larger Version of this Image (20K GIF file)]

The validity of this fitting procedure was also verified using simulated data. Extinction coefficients and reduced molecular weights were fixed at the experimental values for RNase L and HO-2',5'-A3. Data were simulated according to Scheme 1 with a loading concentration of 0.5 µM enzyme and 1, 3, and 10 µM activator. Random Gaussian noise of amplitude 0.0062 r.m.s. was added to corresponding to typical data obtained with our XL-A centrifuge. With values of Ka and Kd fixed at the experimental determined values from Table I, the fitting procedure recovers the correct values with 1 S.D. joint confidence intervals of 1.31-1.89 µM for Ka and 15.1-21.8 nM for Kd. The slightly greater width of the experimental confidence intervals presumably reflects the contributions of small systematic errors in the fixed parameters.

Table I also shows values of Ka and Kd and r.m.s. errors obtained from fitting the same sedimentation data to an alternative association model in which E dimerizes to form E2, which is then competent to bind two activator molecules to form E2A2 (Scheme 2). In this case, Ka is found to be 7 orders of magnitude lower than in the previous fit, and Kd is significantly higher. The r.m.s. deviation is also elevated relative to the previous fit.
<UP> </UP><AR><R><C><UP>2E </UP><LIM><OP><ARROW>⇄</ARROW></OP><UL><UP>K</UP><SUB><UP>d</UP></SUB></UL></LIM><UP> E</UP><SUB><UP>2</UP></SUB></C></R><R><C><UP>+ </UP></C></R><R><C><UP>2A</UP></C></R><R><C><UP>K<SUB>a</SUB>⇵ </UP></C></R><R><C><UP>E<SUB>2</SUB>A<SUB>2</SUB></UP></C></R></AR>
<UP><SC>  Scheme</SC> 2</UP>

To compare directly the sedimentation equilibrium and fluorescence anisotropy methods, we characterized one of the fluorescent activators, HO-2',5'-A3-2'-7HC, using the sedimentation equilibrium protocol. Initial measurements indicated that Kd for the activator is significantly lower than for HO-2',5'-A3. Therefore we have obtained sedimentation equilibrium data at a lower enzyme concentration of 0.2 µM and three activator concentrations of 0.2, 0.6, and 2 µM. As shown in Table I, the best fit parameters for HO-2',5'-A3-2'-7HC are Ka = 2.67 µM and Kd = 1.72 nM. The joint confidence intervals for this fit are much broader than for HO-2',5'-A3, so that the change in Ka relative to HO-2',5'-A3 is not statistically significant. However, the decrease in Kd is significant. As in the case of HO-2',5'-A3, simulations were performed with the experimentally derived parameters and Gaussian noise of 0.0062 OD r.m.s. amplitude. Again, the correct values of Ka and Kd are recovered from the fitting procedure with joint confidence intervals of 1.50-8.62 µM for Ka and 0.19-4.35 nM for Kd. Thus, the increased breadth in the confidence intervals for the fit of HO-2',5'-A3-2'-7HC are also reflected in the simulations.

Fluorescence Anisotropy

A fluorescence activator binding assay was developed to characterize independently the equilibria depicted in Scheme 1. Fluorescent activators, synthesized from 2',5'-oligoadenylate precursors containing a single 2'-NH2 moiety, were prepared by standard amine coupling reactions. We found that activator conjugates with the NHS ester of NHS-7HC exhibited very useful fluorescence properties. Coupling reactions were characterized by HPLC and spectrophotometry. The product was identified based on the appearance of an HPLC peak with retention time different from either unconjugated oligonucleotide or the reactive fluorophore. In all cases, a single predominant product was formed in the reaction. No new HPLC peaks were formed in a reaction of NHS-7HC with HO-2',5'-A3 lacking a 2'-NH2 group. Thus, the chemistry is specific for the 2'-NH2 group. The identity of the product was confirmed by absorption spectrophotometry. In aqueous solution, the NHS-7HC exhibits one predominant absorption band at 415 nm without appreciable absorption near 260 nm. In contrast, the product p-2',5'-A3-7HC exhibits two absorption bands at 405 and 260 nm. Thus, the absorption spectral features are consistent with the proposed structure.

The fluorescence emission parameters of p-2',5'-A3-7HC are summarized in Table II. The emission maximum is at 446 nm (uncorrected). Addition of a slight molar excess of RNase L results in about 60% quenching in the fluorescence amplitude and a slight shift in the emission maximum to 451 nm. A dramatic effect is observed in steady-state fluorescence anisotropy, which increases from 0.05 to 0.33 upon binding RNase L. Further addition of RNase L does not result in appreciable increase in the fluorescence changes. Table II also shows that the fluorescence lifetime is 3.5 ns in the absence and 3.4 ns in the presence of RNase L. Because there is no marked change in the lifetime, the observed increase in anisotropy of p-2',5'-A3-7HC observed upon binding to RNase L is clearly due to an increase in the rotational correlation time.3 Similar spectral perturbations and anisotropy increases are observed for HO-2',5'-A3-7HC, which lacks a 5' phosphate.4 Because the anisotropy increase is very large upon binding, we have chosen to use this parameter for quantitative characterization of the dissociation constants.

Table II. Fluorescence changes for RNase L binding to p-2',5'-A3-7HC

Samples were prepared at 20 °C in buffer containing 11 mM HEPES, pH 7.5, 104 mM KCl. 5.8 mM MgCl2, and 2 mM DTT.

Sample  lambda maxa Intensityb Anisotropyc Lifetimed

nm % ns
50 nM Activator 446 100 0.050 3.5
+60 nM RNase L 451 36 0.327 3.4
+200 nM RNase L 451 39 0.332 3.4

a Fluorescence emission maximum. Excitation was at 404 nm (16 nm bandpass).
b Intensity at 446 nm.
c Emission anisotropies were measured in the L-configuration using a KV-470 Schott long pass filter with experimentally determined G-factors.
d Fluorescence lifetimes were measured by phase modulation from 5 to 190 MHz. Emission was collected using a KV-470 Schott long pass filter.

The interaction of p-2',5'-A3-7HC with RNase L is too strong to be readily characterized by fluorescence anisotropy experiments, where the lowest accessible fluorophore concentration is about 2 nM. However, the values of Ka and Kd for HO-2',5'-A3-7HC, which lacks a 5'-phosphate, are accessible to fluorescence measurements. Fig. 4 shows a series of RNase L titrations performed at four activator concentrations ranging from 5 to 50 nM. At each activator concentration the anisotropy shows a pseudo-hyperbolic increase with increasing enzyme concentration. The plateau value of the anisotropy observed at the highest enzyme concentration of 2 µM decreases with decreasing activator concentration. In contrast, the half-maximum point is not strongly dependent on activator concentration. We have globally fit these data to Equations 6 and 7. To reduce the number of floating parameters it is necessary to constrain the value of the emission anisotropy of EA, rEA. The two limiting cases we have considered are rEA = rf and rEA rb. Fig. 4 shows a fit of the data assuming rEA = rf, and the fitted parameters are in Table III. The fitted curves overlay the data quite well (r.m.s. deviation of 0.0131), and the best fit values of Ka = 1.32 µM and Kd = 1.09 nM agree well with those determined by sedimentation; however, the joint confidence intervals are much narrower for the fluorescence results. A much poorer fit is obtained assuming rEA = rb (r.m.s. = 0.0229), and the values of Ka = 44.1 µM and Kd near 1 pM are not compatible with the sedimentation data. We have also considered the intermediate model in which rEA = rb/2. The quality of this fit is intermediate between the two former cases (r.m.s. = 0.0204), and the values of Ka and Kd are close to that determined assuming rEA = rf. In all of these cases we have also assumed that the 60% quenching only occurs upon dimerization of EA to form E2A2. However, the values of the equilibrium constants and the fit quality are not very sensitive to the extent of quenching of EA. We conclude that the simplest model capable of fitting the data is that the anisotropy of HO-2',5'-A3-7HC is not strongly changed upon complexation to EA but increases dramatically upon dimerization of EA.


Fig. 4. Anisotropy titration of HO-2',5'-A3-7HC with RNase L. Activator concentrations: open circle , 5 nM; square , 10 nM; triangle , 20 nM; diamond , 50 nM. The solid lines are a global fit of the data to Scheme I, and the results are summarized in Table III.
[View Larger Version of this Image (21K GIF file)]

Table III. Ka and Kd values for HO-2',5'-A3-7HC determined by fluorescence anisotropy titration

Samples were prepared at 20 °C in buffer containing 11 mM HEPES, pH 7.5, 104 mM KCl, 5.8 mM MgCl2, and 2 mM DTT. Data were collected using the same conditions as in Table II with activator concentrations of 5, 10, 20, and 50 nM and were globally fit to obtain Ka and Kd. The values in parentheses refer to the 1 S.D. joint confidence intervals.

Modela Ka Kd r.m.s.b

µM nM
rEA = rf 1.32 (1.04, 1.76) 1.09 (0.63, 1.71) 0.0131
rEA = rb 44.1 9.65 × 10-4 0.0229
rEA = rb/2 1.87 0.75 0.0204

a The data were fit according to Equations 6 and 7 using three different assumptions regarding the anisotropy of the EA species. For details, see "Results."
b Root mean square deviation of the fit in anisotropy units.


DISCUSSION

The sedimentation equilibrium and fluorescence data presented here define the energetics of RNase L activation by the 2',5'-linked adenosine trimers HO-2',5'-A3 and HO-2',5'-A3-7HC and provide support for the minimal activation model presented in Scheme 1. For these activators, Ka is in the low micromolar range, and Kd is in the low nanomolar range. The value of Kd is decreased by about 10-fold for the latter activator relative to HO-2',5'-A3. Despite the correlation of the Ka and Kd parameters in fitting the sedimentation and fluorescence data, global analysis of data obtained over a range of activator and/or enzyme concentrations gives rise to well defined fit minima and joint confidence intervals. For HO-2',5'-A3-7HC, the lower value of Kd gives rise to broad confidence intervals for the sedimentation fitting parameters. However, the confidence intervals for the anisotropy parameters are quite narrow, and there is good agreement between the best fit values of Ka and Kd for this activator determined by the two independent methods.

The values of Ka and Kd obtained by sedimentation equilibrium may also be compared with those determined by kinetic methods (7). Using a model that explicitly accounts for substrate binding, we have found that for a given activator, Ka and Kd are dependent on the identity of the substrate: Ka is about 3-fold higher for C11U2C7 than for C11UC8, whereas Kd is about 5-fold lower. The parameters obtained by sedimentation measurements for HO-2',5'-A3 agree more closely with the kinetic data obtained with poorer substrate C11UC8, such that Ka and Kd determined by the two methods are within a factor of 2.

The sedimentation equilibrium data are also capable of distinguishing the activation model presented in Scheme 1 from the alternative model in Scheme 2. In the latter case, the enzyme monomer is capable of dimerization prior to binding activator. Although both models are consistent with our earlier stoichiometry measurements, the absence of any detectable dimer in the absence of activator at enzyme concentrations up to at least 18 µM strongly suggested that activator binding precedes dimerization (4). In the present study, the data fit well to the model in Scheme 1, but the large increase in r.m.s. for the alternative model (Scheme 2) indicates that it does not describe the data adequately. Most importantly, the deduced value of Kd = 138 nM is not consistent with the absence of measurable dimerization of free enzyme at micromolar concentrations. Thus, Scheme 1 represents the minimal model capable of describing the sedimentation equilibrium data.

The fluorescence anisotropy data are also consistent with the model in Scheme 1, but they cannot easily be used to distinguish different models because of the need to constrain the value of rEA. The binding data obtained at several activator concentrations fit well to Scheme 1 if it is assumed that the anisotropy increase only occurs upon dimerization of EA and fit less well to models that invoke an increase in anisotropy upon binding of A to E to form EA. This observation is surprising, since one might expect that the mobility of the fluorophore would be at least partially restricted upon binding, especially given the short linker between the oligoadenylate moiety and the fluorophore. It is likely that some anisotropy increase upon formation of EA does actually occur but is masked by the very large increase observed upon dimerization to E2A2. In any case, the fitted values of Ka and Kd are not strongly dependent on the value of rEA.

It is noteworthy that RNase L is monomeric at protein concentrations up to at least 18 µM, whereas in the presence of activator the Kd for dimerization is in the nanomolar range. Thus, activator binding increases dimerization affinity by a factor of at least 105-106, corresponding to strong thermodynamic linkage. The structural basis of this linkage is not yet clear. The activator binding site may be distant from the dimerization interface and modulate dimerization via a long range conformational change. Alternatively, activator binding may occur at or near the dimerization interface and directly modify the interactions that govern dimerization. There is precedence for strong linkage between dimerization and ligand binding in the Escherichia coli Rep helicase system. In the absence of DNA, Rep exists as a monomer at concentrations of at least 8 µM (13). However, dimerization is induced upon binding DNA with a Kd of about 5 nM, indicating an enhancement of dimerization of at least 104-fold (14).

The strong coupling of enzyme dimerization to activator binding presumably represents a physiological mechanism to control RNase L activity. The enzyme kinetic data suggest that monomeric RNase L is inactive (7), and the ability of various oligoadenylates to activate RNase L correlates with enzyme dimerization (3). Synthesis of 2',5'-linked oligoadenylates is performed by a family of double-stranded RNA-activated synthetases which are induced by interferon treatment (15). Although there are low, basal levels of RNase L expression in most mammalian cells (less than one part in 500,000 of the protein in mouse liver), it is also induced during interferon treatment (16). According to Scheme 1, formation of E2A2, and therefore the specific activity of RNase L, is dependent on the concentrations of both E and A. Coordinate induction of 2',5'-linked oligoadenylate synthetases and RNase L by interferon would serve to prime the system for a high level of RNase L activity upon activation of the synthetases by double-stranded RNA.


FOOTNOTES

*   The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1   The abbreviations used are: DTT, dithiothreitol; HO-2',5'-A3, 2',5'-linked adenosine trimer; p-2',5'-A3, 2',5'-linked adenosine trimer with a 5'-monophosphate; NHS-7HC, 7-hydroxycoumarin-3-carboxylic acid, succinimidyl ester; HPLC, high performance liquid chromatography; HO-2',5'-A3-7HC, conjugate of HO-2',5'-A3-2'-NH2 and 7-hydroxycoumarin-3-carboxylic acid, succinimidyl ester; Me2POPOP, 1,4-bis-2-(4-methyl-5-phenyloxazolyl)-benzene; r.m.s., root mean square.
2   J. L. Cole, unpublished observations.
3   For a simple system with a single fluorescence lifetime (tau ) and a single rotational correlation time (phi ), the steady-state anisotropy is given by r = r0/(1 + (tau /phi )), where r0 is the intrinsic anisotropy in the absence of rotation. Thus, a change in the value of r can be ascribed to change in phi  only if independent fluorescence lifetime measurements indicate that tau  is constant.
4   J. L. Cole and E. S. Blue, unpublished observations.

ACKNOWLEDGEMENTS

We thank Fritz Benseler for suggesting the use of a 2'-amino group for synthesis of fluorescent activators and Marc Lewis for help with the mathematical formalism for the analysis of heterogeneous associations.


REFERENCES

  1. Kerr, I. M., and Brown, R. E. (1978) Proc. Natl. Acad. Sci. U. S. A. 75, 256-260 [Abstract]
  2. Hovanessian, A. G., and Wood, J. N. (1980) Virology 101, 81-90 [Medline] [Order article via Infotrieve]
  3. Dong, B., and Silverman, R. H. (1995) J. Biol. Chem. 270, 4133-4137 [Abstract/Free Full Text]
  4. Cole, J. L., Carroll, S. S., and Kuo, L. C. (1996) J. Biol. Chem. 271, 3979-3981 [Abstract/Free Full Text]
  5. Wyman, J., and Gill, S. J. (1990) Binding and Linkage: Functional Chemistry of Biological Macromolecules, pp. 203-236, University Science Books, Mill Valley, CA
  6. Wong, I., and Lohman, T. M. (1995) Methods Enzymol. 259, 95-127 [Medline] [Order article via Infotrieve]
  7. Carroll, S. S., Cole, J. L., Viscount, T., Geib, J., Gehman, J., and Kuo, L. C. (1997) J. Biol. Chem. 272, 19193-19198 [Abstract/Free Full Text]
  8. Carroll, S. S., Chen, E., Viscount, T., Geib, J., Sardana, M. K., Gehman, J., and Kuo, L. C. (1996) J. Biol. Chem. 271, 4988-4992 [Abstract/Free Full Text]
  9. Lakowicz, J. R. (1983) Principles of Fluorescence Spectroscopy, p. 88, Plenum Press, New York
  10. Lewis, M. S., Shrager, R. I., and Kim, S.-J. (1994) in Modern Analytical Ultracentrifugation (Shuster, T. M., and Laue, T. M., eds), pp. 94-115, Birkhauser, Boston
  11. Beechem, J. M., Gratton, E., Ameloot, M., Knutson, J. R., and Brand, L. (1991) in Topics in Fluorescence Spectroscopy (Lakowicz, J., ed), pp. 241-305, Plenum Press, New York
  12. Johnson, M. L., and Faunt, L. M. (1992) Methods Enzymol. 210, 1-37 [Medline] [Order article via Infotrieve]
  13. Chao, K., and Lohman, T. M. (1991) J. Mol. Biol. 221, 1165-1181 [CrossRef][Medline] [Order article via Infotrieve]
  14. Wong, I., Chao, K. L., Bujalowski, W., and Lohman, T. M. (1992) J. Biol. Chem. 267, 7596-7610 [Abstract/Free Full Text]
  15. Hovanessian, A. G., Brown, R. E., and Kerr, I. M. (1977) Nature 268, 537-539 [Medline] [Order article via Infotrieve]
  16. Silverman, R. H., Jung, D. D., Nolan-Sorden, N. L., Dieffenbach, C. W., Kedar, V. P., and SenGupta, D. N. (1988) J. Biol. Chem. 263, 7336-7341 [Abstract/Free Full Text]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.